Track topics on Twitter Track topics that are important to you
Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe
Original Article: Novartis claims EU approval for breast cancer drug KisqaliNEXT ARTICLE
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have colleagues in 180 countries. Lipitor, one of its produ...